Has Blair Wagoner received payments from drug or device companies?

Yes. Drug and device makers reported $3,306 in general payments to Blair Wagoner across 171 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Blair Wagoner did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Blair Wagoner come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Blair Wagoner

Psychiatric/Mental Health · Richmond, INNPI 1366220907

Payments from drug & device makers

$3,306in general payments, 2019–2025

Across 171 payments — averaging $19.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$646
Vanda Pharmaceuticals Inc.$529
Neurocrine Biosciences, Inc.$491
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$332
Alkermes, Inc.$237
Otsuka America Pharmaceutical, Inc.$228
plus $844 from 13 others

What the payments were for

Food & beverage$3,294100%
Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	40	$646
Vanda Pharmaceuticals Inc.	20	$529
Neurocrine Biosciences, Inc.	22	$491
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	14	$332
Alkermes, Inc.	15	$237
Otsuka America Pharmaceutical, Inc.	13	$228
Corium, LLC	11	$158
Johnson & Johnson	2	$100
Lundbeck LLC	5	$98
E.r. Squibb & Sons, L.L.C.	6	$94
Teva Pharmaceuticals USA, Inc.	6	$90
Ironshore Pharmaceuticals Inc.	4	$64
Tris Pharma Inc	3	$56
Supernus Pharmaceuticals, Inc.	2	$47
Axsome Therapeutics, Inc.	2	$40
Collegium Pharmaceutical, Inc.	2	$33
Indivior Inc.	2	$32
Takeda Pharmaceuticals U.S.A., Inc.	1	$18
Neos Therapeutics, LP	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,306 in reported general payments places this provider in the 85th percentile of 729 psychiatric/mental health providers in Indiana.

See all psychiatric/mental health providers in Indiana →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Invega SustennaPaliperidone Palmitate	55	$186,975
Invega TrinzaPaliperidone Palmitate	12	$105,656
FanaptIloperidone	15	$42,806
LatudaLurasidone Hcl	11	$29,342
Risperdal ConstaRisperidone Microspheres	11	$24,406
Paliperidone ErPaliperidone	45	$8,083
Aripiprazole	85	$7,162
Lurasidone Hcl	48	$4,745
Quetiapine Fumarate ErQuetiapine Fumarate	12	$4,119
Divalproex Sodium ErDivalproex Sodium	48	$3,835
Olanzapine	41	$3,194
Perphenazine	12	$1,854
Quetiapine Fumarate	94	$1,843
Haloperidol	44	$1,713
Desvenlafaxine Succinate ErDesvenlafaxine Succinate	13	$1,449

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Johnson & JohnsonInvega Sustenna, Invega Trinza, Risperdal Consta	$100	$317,03778 claims
Vanda Pharmaceuticals Inc.Fanapt	$529	$42,80615 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 729 psychiatric/mental health providers in Indiana.

Other psychiatric/mental health in Richmond

Courtney FullmerRichmond$6K
Brooke KempfTerre Haute$1.1M
Gerald LewisMerrillville$336K
Lauren LutzColumbus$320K
Sonya RuedlingerIndianapolis$134K
Trina GreenwaldMarion$107K
Paul DuncanJeffersonville$46K
Morgan StamperConnersville$42K
Jennifer JimenezUnion Mills$37K
Savannah MullinsClarksville$31K

See the full list for Indiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →